Cargando…
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
The lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a secreted, hyperglycosylated protein expressed by the majority of human cells. It was first identified as cancer and metastasis associated protein, while its role in innate immune response upon viral infection remains still to b...
Autores principales: | Capone, Emily, Iacobelli, Stefano, Sala, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474792/ https://www.ncbi.nlm.nih.gov/pubmed/34565385 http://dx.doi.org/10.1186/s12967-021-03085-w |
Ejemplares similares
-
Visualizing
Galectin-3 Binding Protein Expression
with ImmunoPET
por: Keinänen, Outi, et al.
Publicado: (2023) -
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma
por: Capone, Emily, et al.
Publicado: (2017) -
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
por: Gandullo‐Sánchez, Lucía, et al.
Publicado: (2020) -
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target
por: Capone, Emily, et al.
Publicado: (2023) -
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors
por: Capone, Emily, et al.
Publicado: (2021)